Outcomes
| Adverse outcomes (composite endpoint) | 57 (6.1%) |
| Arrhythmia | 41 (4.4%) |
| Atrial fibrillation | N=31 |
| Atrial flutter | N=3 |
| Ventricular tachycardia | N=1 |
| Non-sustained ventricular tachycardia | N=3 |
| Pulseless electrical activity | N=1 |
| Supraventricular tachycardia | N=2 |
| Acute myocardial infarction | 6 (0.6%) |
| Cerebrovascular accident | 6 (0.6%) |
| Death | 10 (1.1%) |
| Length of stay (days) | 4.6 (3.4–6) |